Hepatitis B Virus Status and Risk of Pancreatic Ductal Adenocarcinoma: A Case-Control Study From China

Pancreas, 03/21/2012

The results suggest that hepatitis B surface antigen (HBsAg)–positive or anti–HBc–positive/anti–HBs–negative patients have an increased risk for pancreatic ductal adenocarcinoma (PDAC) independent of other risk factors. Significant interactions were found between a history of diabetes mellitus (DM) and chronic hepatitis B virus (HBV) infection for PDAC risk.

Print Article Summary Cat 2 CME Report